Henry Yellson

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: United States

Consulting Services

Legal Support Data Science-Bioinformatics Scientific Writing Biostatistics Sales and Marketing

Areas Of Interest

Post-Concussive Syndromes, Chronic Euodia ruticarpa Encephalopathy, Mercury EEDTs (Eosinophil Extracellular DNA Traps) p65(gag-jun) Receptors, Orphan Nuclear Kv4.3 Potassium Channel Nanocrystal, Metal Surgical Procedure, Urogenital Taurochenodeoxycholic Acid Adenomatoses, Multiple Endocrine Chests ras Proto-Oncogene Product p21 Absorption, Buccal Sequence Databases, RNA Vumon Resistance, Systemic Vascular Inhibitors, P450 CYP2E1 Amlodipine Besylate, Olmesartan Medoxomil Hemorrhagic Fevers, Epidemic Discolorations, Tooth Break-Bone Fever Eukaryotic Peptide Initiation Factor-2 v-fos Proteins Suidae Apium graveolens var. rapaceum Inappropriate Prescription Inverse Agonism, Drug Phyllotemp Nuns

Professional Narrative

Dr. Henry Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Mayo Clinic 1987
Executive Director, Harvard Med 2004

Education

Master of Science in physician assistant, Perelman School of Medicine 1997
Bachelor of science in nursing, Weill Medical College 1993

Referees

Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02